Impact of type 2 diabetes on oncologic outcomes of hepatocellular carcinomas in non-cirrhotic, non-alcoholic steatohepatitis: a matched-pair analysis

Non-alcoholic steatohepatitis (NASH) associated hepatocellular carcinomas (NASH-HCC) are increasing. NASH-HCC often develops in the fibrotic liver. Several analyses report conflicting results regarding the outcome of non-cirrhotic NASH-HCC. Furthermore, type 2 diabetes (T2D) is considered a risk fac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Billeter, Adrian (VerfasserIn) , Müller, Philip C. (VerfasserIn) , Albrecht, Thomas (VerfasserIn) , Rössler, Stephanie (VerfasserIn) , Löffler, Moritz (VerfasserIn) , Murtha-Lemekhova, Anastasia (VerfasserIn) , Mehrabi, Arianeb (VerfasserIn) , Müller, Beat P. (VerfasserIn) , Hoffmann, Katrin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2021
In: Journal of gastrointestinal surgery
Year: 2021, Jahrgang: 25, Heft: 5, Pages: 1193-1202
ISSN:1873-4626
DOI:10.1007/s11605-020-04628-0
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s11605-020-04628-0
Volltext
Verfasserangaben:Adrian T. Billeter, Philip C. Müller, Thomas Albrecht, Stephanie Roessler, Moritz Löffler, Anastasia Lemekhova, Arianeb Mehrabi, Beat P. Müller-Stich, Katrin Hoffmann
Beschreibung
Zusammenfassung:Non-alcoholic steatohepatitis (NASH) associated hepatocellular carcinomas (NASH-HCC) are increasing. NASH-HCC often develops in the fibrotic liver. Several analyses report conflicting results regarding the outcome of non-cirrhotic NASH-HCC. Furthermore, type 2 diabetes (T2D) is considered a risk factor for poor survival. The aim of this study was to investigate oncological outcomes of non-cirrhotic NASH-HCC and the impact of T2D.
Beschreibung:Published online: 6 May 2020
Gesehen am 31.08.2021
Beschreibung:Online Resource
ISSN:1873-4626
DOI:10.1007/s11605-020-04628-0